Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ranitidine
- Therapeutic area
- Gastrointestinal & hepatology
- Drug class
- H2-receptor antagonists
- ATC
- A02BA
- Strength
- 150mg
- Dosage form
- Tablet
- Pack
- 10's
- Registration no.
- 024782
- Price record verified
- 2026-09-25
- Latest DRAP source check
- 2026-10-05 02:55
Manufacturer
Xenon Pharmaceuticals (Pvt.) Ltd
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 63.45 to 66.58 (+4.9%) between 30 Jun 2026 and 25 Sep 2026 · 2 official price records · pack 10's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Xetac 150mg, 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/xetac-150mg-024782-10s-xenon-pharmaceuticals-pvt-ltd/ (accessed 5 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 66.58 | 2026-09-25 | 2026-09-26 | DRAP PharmaPrice Index (refreshed from snapshot #88) | Current |
| PKR 63.45 | 2026-06-30 | 2026-09-25 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 024782Price and registration data on this page were observed on 26 September 2026. Records change over time, so please cite the observation date alongside the access date.
